Rewind to November 2004. Netherlands-based Akzo Nobels pharmaceutical business Organon announces that the Food and Drug Administration (FDA) has granted approvable status for its etonogestrel subdermal contraceptive implant Implanon. Fast forward to today. Do you see the method added to the U.S. contraceptive mix?
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content